April 6–18 Jay Bharat – Complete Master DashboardApril 6–18, 2026 · Jay Bharat stock analysis · 9844542127 · time on new line

✅ All uploaded screenshots (April 6–18). Source branding cleaned from headlines. Jay Bharat stock analysis dashboard. Date/time parsed from filenames. Action is suggestive, translation simplifies market jargon. Contact: Jay Bharat 9844542127.

#	📅 Date / Time (stacked)	📄 Cleaned Text (headlines)	📖 Translation	⚡ Action	💡 Jay Bharat Idea & Notes
1	📆 06/04/26⏱️ 10:58:00	Smartworks: Expands Managed Office Deal Across Multiple Cities With Forbes 2000 Global Customer; Seats Top 5,000. Indus Towers: IIFL Says Dividend Or Share Buyback Could Be Announced Alongside Q4 Results — CNBC-TV18	📌 Shareholder reward – positive cash return.	BUY	💡 📡 IIFL hints dividend/buyback – potential catalyst.
2	📆 06/04/26⏱️ —	FII Investors Sell India Shares Worth Rs 8,167.17 Crore, While DII Investors Buy Net Rs 8,088.70 Crore Today	📌 Positive brokerage stance – expected upside.	BUY	💡 📌 Monitor earnings / management commentary.
3	📆 06/04/26⏱️ —	Blue Cloud Softech: Company Announces Strategic All-Share Buyout Of Global ImP X Inc To Build An AI-Driven Energy And Digital Infrastructure Platform, Valuing The Target At Rs 372.8 Crore	📌 Positive brokerage stance – expected upside.	BUY	💡 📌 Monitor earnings / management commentary.
4	📆 07/04/26⏱️ 09:28:00	FII Sell Net Rupees 8,692.11 Cr Of India Shares Today \|\| DII Buy Net Rupees 7,979.50 Cr	📌 Foreign outflows, domestic buying offsets – volatility likely.	BUY	💡 📌 Monitor earnings / management commentary.
5	📆 07/04/26⏱️ 12:04:00	Zydus Life: Receives Final USFDA Approval For Dapagliflozin 5 Mg And 10 Mg Tablets, After Annual Sales Of $10.2 Billion	📌 Regulatory approval – opens large market opportunity.	NoAction	💡 💊 Dapagliflozin approval – $10B+ market, generic opportunity.
6	📆 07/04/26⏱️ 21:27:00	Lupin: Co Gets US Approval For Dapagliflozin Plus Metformin Hydrochloride Tablets. Qatar Begins Work To Resume Production At LNG Export Hub. NHPC: CO Approved Investment For 1,720 MW Kamala Hydroelectric Project Worth Rs 260.7 Billion	📌 Corporate action / earnings / market update.	NoAction	💡 💊 Dapagliflozin approval – $10B+ market, generic opportunity.
7	📆 09/04/26⏱️ 14:22:00	Anand Rathi Wealth: Co Approves Final Dividend Of Rs. 7 Per Share. Dilip Buildcon: Company Declared As L1 Bidder For Rs 268 Crore EPC Project For Ged Barrage On Sabarmati River.	📌 Shareholder reward – positive cash return.	BUY	💡 💰 ₹7 dividend – wealth management co, steady yield.
8	📆 09/04/26⏱️ 15:44:00	POSITIONAL CALL: BUY TCS (NSE Symbol TCS) AT 2590 FOR TARGET Of 2850, STOP LOSS 2440.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 💻 Positional buy target 2850 – IT bellwether.
9	📆 09/04/26⏱️ —	TATA CONSULTANCY SERVICES: CO RECOMMENDED A FINAL DIVIDEND OF RS 31 PER EQUITY SHARE	📌 Shareholder reward – positive cash return.	BUY	💡 📌 Monitor earnings / management commentary.
10	📆 09/04/26⏱️ 11:04:00	POSITIONAL CALL: BUY TEJAS NETWORKS (NSE Symbol TEJASNET) AT 458.5 FOR TARGET OF 600, STOP LOSS 380.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 📡 Positional buy target 600 – defence/telecom equipment.
11	📆 09/04/26⏱️ —	POSITIONAL CALL: BUY INDIA GLYCOLS (NSE Symbol INDIAGLYCO) AT 932 FOR TARGET Of 1100, STOP LOSS 840.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 📌 Monitor earnings / management commentary.
12	📆 09/04/26⏱️ 11:06:00	Titan Company: Morgan Stanley maintains Overweight with Target Price ₹5,102 (raised from ₹4,529), citing strong jewellery demand driving 4–8% revenue upgrades, 3–5% EPS increase.	📌 Positive brokerage stance – expected upside.	BUY	💡 💍 MS Overweight TP ₹5102 – jewellery demand strong.
13	📆 10/04/26⏱️ —	NSE Index Ends Up 1.16% Or +275.50 Points At 24,050.60	📌 Corporate action / earnings / market update.	NoAction	💡 📌 Monitor earnings / management commentary.
14	📆 10/04/26⏱️ 12:49:00	HCC: Investor Mukul Agrawal Boosts Stake From 1.68% To 1.91% In Q4	📌 Corporate action / earnings / market update.	NoAction	💡 📈 Ace investor stake increase – sentiment positive.
15	📆 10/04/26⏱️ 09:58:00	Tata Consultancy Services: Morgan Stanley maintains Overweight with Target Price ₹2,880 (cut from ₹3,540), citing in-line Q4 with slight geographic improvement, cautious FY27 outlook.	📌 Positive brokerage stance – expected upside.	BUY	💡 📌 Monitor earnings / management commentary.
16	📆 10/04/26⏱️ 05:14:00	Delhivery: HSBC maintains Hold with Target Price ₹500 (raised), citing resilient share performance despite Middle East fuel inflation concerns, strong near-term demand.	📌 Corporate action / earnings / market update.	HOLD	💡 📌 Monitor earnings / management commentary.
17	📆 10/04/26⏱️ 05:15:00	Tata Consultancy Services: JPMorgan maintains Overweight with Target Price ₹3,150, citing Q4 revenue beat, strong $12bn deal wins, 28% QoQ AI revenue growth.	📌 Positive brokerage stance – expected upside.	BUY	💡 📌 Monitor earnings / management commentary.
18	📆 10/04/26⏱️ 05:15:00	Tata Consultancy Services: Kotak Institutional Equities maintains Buy with Target Price ₹3,100, citing strong bookings with three mega deals.	📌 Positive brokerage stance – expected upside.	BUY	💡 📌 Monitor earnings / management commentary.
19	📆 10/04/26⏱️ 05:16:00	Shriram Finance: Morgan Stanley maintains Overweight with Target Price ₹1,325, citing AAA upgrade by ICRA post MUFG deal, improving credit profile.	📌 Positive brokerage stance – expected upside.	BUY	💡 🏦 MS Overweight TP ₹1325 – AAA upgrade post MUFG deal.
20	📆 10/04/26⏱️ 05:16:00	Tata Consultancy Services: InCred maintains Add with Target Price ₹3,052 (cut from ₹3,663), citing modest beat but cautious demand outlook.	📌 Corporate action / earnings / market update.	NoAction	💡 📌 Monitor earnings / management commentary.
21	📆 10/04/26⏱️ 09:57:00	Tata Consultancy Services: Jefferies maintains Underperform with Target Price ₹2,275, citing margin miss, weak BFSI growth, flat deal bookings.	📌 Negative brokerage view – expected underperformance.	SELL	💡 📌 Monitor earnings / management commentary.
22	📆 10/04/26⏱️ 09:56:00	Tata Consultancy Services: CLSA maintains Outperform with Target Price ₹2,985, citing strong GenAI revenue growth ($2.3bn annualised).	📌 Corporate action / earnings / market update.	BUY	💡 📌 Monitor earnings / management commentary.
23	📆 10/04/26⏱️ 09:56:00	Tata Consultancy Services: Citi maintains Sell with Target Price ₹2,250, citing FY26 revenue decline of 2.4% YoY CC, headcount decline.	📌 Negative brokerage view – expected underperformance.	SELL	💡 📌 Monitor earnings / management commentary.
24	📆 10/04/26⏱️ 09:56:00	Tata Consultancy Services: Goldman Sachs maintains Buy with Target Price ₹2,710, citing strong deal wins including three mega deals.	📌 Positive brokerage stance – expected upside.	BUY	💡 📌 Monitor earnings / management commentary.
25	📆 10/04/26⏱️ 18:30:50	Vakrangee: Ties Up With IndiaFirst Life Insurance To Sell Life Insurance Through Vakrangee Kendra Network, Expanding Coverage In Underserved Areas.	📌 Negative brokerage view – expected underperformance.	SELL	💡 🏪 Insurance tie-up – expanding last-mile distribution.
26	📆 10/04/26⏱️ 18:30:50	Mahindra & Mahindra: Co Divests 99.04% Stake In Erkun Foundry, Turkey, To Hisarlar Makina For ₹256 Cr, Using Funds To Pay Off Debt Ahead Of Schedule.	📌 Corporate action / earnings / market update.	NoAction	💡 🚜 Turkey subsidiary sale – debt reduction positive.
27	📆 10/04/26⏱️ 18:30:50	Muthoot Finance: Company Board Approves ₹30 Dividend Per Share.	📌 Shareholder reward – positive cash return.	BUY	💡 💰 ₹30 dividend – gold financier, high yield.
28	📆 10/04/26⏱️ 20:49:00	Foreign Investors Buys India Shares Net Rs 672.09 Crore Today, While Domestic Investors Buys Net Rs 410.05 Crore.	📌 Foreign inflows positive for sentiment.	BUY	💡 📌 Monitor earnings / management commentary.
29	📆 11/04/26⏱️ —	POSITIONAL CALL: BUY BHARTI AIRTEL AT 1889 FOR TARGET 2200, STOP LOSS 1810.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 📌 Monitor earnings / management commentary.
30	📆 11/04/26⏱️ —	NSE Index Ends Down 0.86% Or -207.95 Points At 23,842.65. Government Says Commercial LPG Supply Is Back Up To 70%.	📌 Corporate action / earnings / market update.	NoAction	💡 📌 Monitor earnings / management commentary.
31	📆 11/04/26⏱️ —	FIIs Sell Net ₹1,983.18 Crore In Indian Shares, While DIIs Buy Net ₹2,432.30 Crore. LIC: Board Approves 1:1 Bonus Share Issue.	📌 Positive brokerage stance – expected upside.	BUY	💡 🏦 1:1 bonus share – PSU giant, retail sentiment boost.
32	📆 12/04/26⏱️ —	POSITIONAL CALL: BUY PB FINTECH (POLICYBAZAAR) AT 1538 FOR TARGET 1800, STOP LOSS 1380.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 📌 Monitor earnings / management commentary.
33	📆 13/04/26⏱️ —	HDFC AMC: Q4 REVENUE 10.5B VS 9B (YoY). POSITIONAL CALL: BUY SYNGENE AT 434 TARGET 570.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 📌 Monitor earnings / management commentary.
34	📆 13/04/26⏱️ —	HDFC AMC: Q4 NET PROFIT 6.23B VS 6.4B. ADANI PORTS BLOCK TRADE. HDFC AMC DIVIDEND ₹54.	📌 Shareholder reward – positive cash return.	BUY	💡 📌 Monitor earnings / management commentary.
35	📆 13/04/26⏱️ —	WAAREE RENEWABLE: Q4 EBITDA 2.06B VS 1.26B. Angel One raises borrowing limit to ₹200B.	📌 Corporate action / earnings / market update.	NoAction	💡 ☀️ Strong Q4 profit growth (65% YoY) – solar energy leader.
36	📆 13/04/26⏱️ —	WAAREE RENEWABLE: Q4 NET PROFIT 1.55B VS 938M. Angel One: Q4 EBITDA 6B VS 3.43B, margin 41%.	📌 Quarterly earnings release – compare YoY/QoQ trends.	NoAction	💡 ☀️ Strong Q4 profit growth (65% YoY) – solar energy leader.
37	📆 13/04/26⏱️ —	VST INDUSTRIES: Final Dividend ₹12. Q4 Net Profit 1.16B VS 513M, Revenue 6.9B VS 4.54B.	📌 Shareholder reward – positive cash return.	BUY	💡 📊 Dividend ₹12 + profit doubled – strong tractor/auto ancillary.
38	📆 13/04/26⏱️ —	VST INDUSTRIES: Q4 EBITDA 2.08B VS 695M, margin 30.23% VS 15.32%. Dow Jones +108 pts.	📌 Corporate action / earnings / market update.	NoAction	💡 📊 Dividend ₹12 + profit doubled – strong tractor/auto ancillary.
39	📆 17/04/26⏱️ —	POSITIONAL CALL: BUY CONCORD BIOTECH AT 1100 TARGET 1450, STOP 980.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 💊 Positional buy target 1450 – biopharma speciality.
40	📆 17/04/26⏱️ —	POSITIONAL CALL: BUY FEDERAL BANK AT 290 TARGET 330, STOP 270.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 🏦 Positional buy target 330 – valuation attractive.
41	📆 17/04/26⏱️ —	POSITIONAL CALL: BUY ANGEL ONE AT 316.75 TARGET 430, STOP 243.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 📈 Q4 EBITDA doubled – brokerage growth story.
42	📆 17/04/26⏱️ —	POSITIONAL CALL: BUY SBI AT 1077 TARGET 1160, STOP 1044.	📌 Derivative/equity long recommendation (speculative, high risk).	BUY	💡 🏦 Positional buy target 1160 – PSU bank recovery.
43	📆 18/04/26⏱️ 17:25:00	ICICI BANK: Q4 INTEREST EARNED 433B VS 424B (YoY).	📌 Corporate action / earnings / market update.	NoAction	💡 📌 Monitor earnings / management commentary.
44	📆 18/04/26⏱️ —	ICICI BANK: Q4 GNPA 1.40% VS 1.53% (QoQ) \|\| NNPA 0.33% VS 0.37% (QoQ). Provisions 961M VS 25.55B (QoQ).	📌 Asset quality update – lower NPAs indicate improving credit health.	BUY (improving asset quality)	💡 📌 Monitor earnings / management commentary.
45	📆 18/04/26⏱️ —	YES BANK: Q4 GNPA 1.3% VS 1.5% (QoQ) \|\| NNPA 0.2% VS 0.3% (QoQ).	📌 Asset quality update – lower NPAs indicate improving credit health.	BUY (improving asset quality)	💡 🏦 Asset quality improves – turnaround story.
46	📆 18/04/26⏱️ —	Interarch Building Solutions: Secures Rs 60 Crore Order. ICICI BANK: Final Dividend ₹12.	📌 Shareholder reward – positive cash return.	BUY	💡 📌 Monitor earnings / management commentary.
47	📆 18/04/26⏱️ —	HDFC BANK: Q4 GNPA 1.15% VS 1.24% (QoQ) \|\| NNPA 0.38% VS 0.42% (QoQ). Dividend ₹13.	📌 Shareholder reward – positive cash return.	BUY	💡 📌 Monitor earnings / management commentary.

No results found